BUPA is pretty cheap (maybe 1/5 of a US health policy if healthy and young down to 1/25 or less if you have pre-existing conditions) because it's just an add-on to NHS.

But not in the context of a startup which is the context I was talking about your right a lot of the big firms on the FTSE will offer BUPA or somthing similar.